• <xmp id="s8oec">
    <menu id="s8oec"><code id="s8oec"></code></menu><menu id="s8oec"><menu id="s8oec"></menu></menu>
  • <xmp id="s8oec"><menu id="s8oec"></menu>
  • P

    roductsand services

    Innovative Drugs

    Home > Products & services > Innovative Drugs

    SPN003 / SPN004

    Candidate drug screening is going to be completed.

    SPN003/SPN004 are  innovative peptide drugs with synergistic effect on target,  with metabolic diseases including type 2 diabetes and obesity as the main indications.

    SPN007

    Candidate drug screening  has been completed, preclinical studies  are under way.

    SPN007 is a new polypeptide drug with proprietary intellectual property rights. Its indications have expanded from simply lowering blood glucose levels in type 2 diabetes to treating obesity and non-alcoholic fatty liver disease (NASH).

    SPN009

    At the stage of preclinical studies.

    Spn009 is an innovative long-acting hypoglycemic drug  for type 2 diabetes mellitus.

    SPN-X

    At the stage of candidate drug screening.

    SPN-X is a peptide inhibitor against the novel coronavirus main protease.

    Mobile version

    Contact

    Sales Department:
    +86-571-88671330
    +86-571-88671216

    快三计划 <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <文本链> <文本链> <文本链> <文本链> <文本链> <文本链>